Microbiota dysbiosis and gut barrier dysfunction associated with non-alcoholic fatty liver disease are modulated by a specific metabolic cofactors combination
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors
Cleveland Clinic, Yeast Infections
Mitochondrial regulation of -cell function: maintaining the momentum for insulin release
Cyanobacteria-from the oceans to the potential biotechnological and biomedical applications
Many patients with undiagnosed MCAS present with a constellation of neurological and psychiatric symptoms, anxiety, panic attacks, mood instability, brain fog, and sensory sensitivity that overlap with autoimmune conditions